Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ISRGIntuitive SurgicalFinished

IS-002 Phase 2 Prostate Cancer Study

Prostate Cancer

10Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

  • Main results were due May 2024, none posted yet

    Counts until it's fixed

    +10
Worry score10

Score over time

Stage
Phase 2
Patients
59 (final count)
Started
Jun 16, 2023
Main results expected
May 21, 2024
Fully finished
May 23, 2025
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • The proportion of subjects with ≥1 positive surgical margins (PSMs) on final histopathologic assessment in the Intervention arm and the Control arm.

    Measured over: Within 3 months post-surgery

  • The mean number of positive surgical margins (PSMs) on final histopathologic assessment in the Intervention arm and the Control arm.

    Measured over: Within 3 months post-surgery

Changes Tremor has spotted

No changes since Tremor started watching this trial.
Show details (technical version)

Score inputs

  • results_overdue: base 10, now 10, since 2024-05-21, no fading

Raw record changes

  • none yet

Trial ID NCT05946603 · record last updated 2025-09-04 · checked 2026-11-09 15:47 UTC

See the official record on ClinicalTrials.gov (NCT05946603) ↗